Viking Therapeutics VKTX
NASDAQ VKTX
$28.44 -0.22 (-0.77%)
At close: Nov 11, 2026 · 4:00 PM EST

Viking Therapeutics (VKTX) Liabilities and Shareholders Equity (2014 - 2026)

Updated

Analysis

Viking Therapeutics (VKTX) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Viking Therapeutics 3.65 Bn 884.58 Mn - 977.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 977.17 Mn
Jun 30, 2026 521.90 Mn
Mar 31, 2026 608.24 Mn
Dec 31, 2025 715.73 Mn
Sep 30, 2025 739.42 Mn
Jun 30, 2025 827.85 Mn
Mar 31, 2025 866.99 Mn
Dec 31, 2024 908.32 Mn
Sep 30, 2024 937.89 Mn
Jun 30, 2024 946.84 Mn
Mar 31, 2024 967.52 Mn
Dec 31, 2023 368.49 Mn
Sep 30, 2023 382.66 Mn
Jun 30, 2023 400.69 Mn
Mar 31, 2023 150.90 Mn
Dec 31, 2022 168.53 Mn
Sep 30, 2022 166.68 Mn
Jun 30, 2022 181.51 Mn
Mar 31, 2022 195.03 Mn
Dec 31, 2021 210.66 Mn
API Access

Viking Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VKTX&period=max&api_key=YOUR_API_KEY